logo

HEALTHTECH BAROMETER H1 2022

Twice a year Euronext publishes a HealthTech Barometer to showcase the trends and key figures of the biotech companies listed on the Euronext markets.

Download the H1 2022 edition to discover performance indicators, the evolution of investor interest and market sentiment.

Get access to the
barometer

KEY INSIGHTS OF THE REPORT

Get access to the report 

About Post-Listing Advisory

The Healthtech Barometer H1 2022 was created by Euronext Primary Markets team specialized in HealthTech. Providing value-added services to issuers since 2015, our team of advisors assists senior management at listed SMEs, providing advisory and decision-making analytics to deliver on their strategic ambition in the capital markets.

Euronext Post-Listing Advisory offers a full range of services and a dedicated team to support your annual listing roadmap:

  • Annual ‘360° listing diagnostic’
  • Preparation and feedback memos
  • Board reports
  • Weekly market updates
  • Analysts’ consensus updates
  • Institutional data alerts

Request your demo

52118_EN-ECS-Post-Listing Advisory-update_GIF

Follow us on LinkedIn

linkedin-1

Euronext Corporate Services B.V. is incorporated under the laws of The Netherlands (Chamber of Commerce in Amsterdam under Registration no 68034970), having its registered office at Beursplein 5 (1012 JW) Amsterdam, The Netherlands. Euronext Corporate Services B.V. is part of the Euronext Group and a fully-owned subsidiary of Euronext N.V.